I think the run on NAL in the past few days has been due to expected announcement on Thymus deal. The Ladd news was expected as everyone new that production was underway. Sell down today could be due to:
1) Traders buying on expected announcement and volume etc....many sell following announcement
2) Traders who bailed out if stop losses were triggered.
3) people selling for profit.
As with all biotechs price can fluctuate alot. An announcement regarding the Thymus research and possible deal with us pharmaceutical company is what will drive the price. Expect big things if and when this occurs. I'm happy to hold a few for the medium term.
My thoughts only.
Regards
Doyle
- Forums
- ASX - By Stock
- NAL
- ladd
ladd, page-2
Featured News
Add NAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online